Before anything else: Hers serves women only and Maximus serves men only, so in almost every case one of these two is simply not open to you. That makes the price gap secondary, though it is worth knowing. Hers lists hair loss treatment starting at $12.67 a month as of 2026-07-22, for minoxidil 2% topical solution. Maximus lists oral hair protocols starting at $24.99 a month as of 2026-05-07. Both companies also sit behind an open FDA warning letter, and both sell compounded blends alongside their entry product, which is where the real reading work is.
Hers treats women, Maximus treats men, and that settles most of this
Each brand draws the line itself. Among the situations Hers says its hair loss program is not for is a man looking for hair loss treatment, because Hers serves women only. Maximus states the mirror image: its hair protocols are formulated for men, and not for women. There is no overlap to arbitrate.
So treat the rest of this page as background rather than a decision between two options on the same shelf. If you are a woman comparing routes, Hers is the one of these two that will take you, and your real comparison is against other women's programs. If you are a man, Maximus is the one of these two that will take you, and your real comparison is against other men's protocols.
The two do agree on one boundary, and it is the one worth respecting. Hers says scarring alopecia or sudden patchy loss needs an in-person diagnosis first. Maximus says the same about needing an in-person scalp evaluation. Hers additionally lists pregnancy, or planning a pregnancy, as a reason its hair loss program is not for you. Both are United States only.
- Hers: women only, by its own eligibility notes
- Maximus: formulated for men, by its own eligibility notes
- Both: sudden patchy loss or scarring alopecia belongs in an in-person exam first
- Both: United States only, no international shipping
The cheapest item on each side is a single ingredient
On both services, the advertised starting price belongs to the plainest product in the catalog, and the blends sit above it. At Hers the entry item is minoxidil 2% topical solution from $12.67 a month as of 2026-07-22. Oral minoxidil is listed from $29 a month, Biotin and Minoxidil gummies and chews from $35 a month, and an all-in-one kit with shampoo from $38 a month.
At Maximus the entry item is oral minoxidil from $24.99 a month as of 2026-05-07. Oral dutasteride is listed from $34.99 a month, a topical Minoxidil+ gel from $44.99 a month, and combination protocols that pair an oral DHT blocker with a targeted topical gel from $59.99 a month.
Two cautions on those numbers. The Maximus figure was last checked on 2026-05-07 and the Hers figure on 2026-07-22, so the Maximus side of this comparison is the staler of the two and worth re-checking on maximustribe.com before you plan around it. And neither figure is a total: a starting price tells you the floor of a catalog, not the cost of the plan a clinician writes for you.
One approval detail matters for the oral route on both sides. Minoxidil tablets hold FDA approval for high blood pressure in adults, not for hair loss, so an oral minoxidil prescription for thinning hair is an off-label use. Hers says so plainly in its own listing. If you are considering the pill rather than the liquid, that is the question to put to the clinician reviewing your case.
- Hers, from $12.67/mo as of 2026-07-22: minoxidil 2% topical solution
- Hers, other listed items: oral minoxidil from $29/mo, gummies and chews from $35/mo, kit with shampoo from $38/mo
- Maximus, from $24.99/mo as of 2026-05-07: oral minoxidil
- Maximus, other listed items: oral dutasteride from $34.99/mo, topical Minoxidil+ gel from $44.99/mo, combination protocols from $59.99/mo
FDA approval status, product by product
This is the clearest difference between the two catalogs, and it is not a difference of price. Topical minoxidil holds FDA approval for women's hair regrowth, and that approved product is exactly what the entry Hers plan is built on. The multi-ingredient items at Hers do not share that status: the Biotin and Minoxidil gummies and chews are compounded Hair Blends carrying no FDA approval and no FDA review of safety, effectiveness or quality, and the postmenopausal serum pairing finasteride with minoxidil is a compounded blend, with no topical finasteride product approved by the FDA at all.
Maximus describes its gels as compounded formulas combining dutasteride, minoxidil, tretinoin and fexofenadine, prepared by a licensed pharmacy and not reviewed by the FDA. Its own eligibility notes say the service is not for you if you want an FDA-reviewed product only. We do not have an approval status in our records for the Maximus oral minoxidil or oral dutasteride listings, so we are not going to assign one.
Dutasteride, the DHT blocker in the Maximus lineup, is prescribed off-label when it is used for hair loss. Treat that as a question to raise at the consultation rather than a detail buried in a product page.
Compounded formulas carry no FDA approval, and the FDA has not reviewed them for safety, effectiveness or quality. That is a statement about what the agency has and has not evaluated, not a verdict on any product, and it applies to items in both catalogs.
A pill, a topical, or a gel that blends four drugs
Format is where the two services genuinely diverge in design. Maximus sells choice as the point: an oral pill, a topical gel, or both, rather than one fixed plan, and it says in its own fit notes that it suits you if you would rather avoid a daily topical routine and take a pill instead. The top of that lineup is the combination protocol, an oral DHT blocker alongside a compounded topical gel.
Hers reads the other way around. The liquid is the anchor, the oral tablet is an alternative, and the rest of the lineup is a set of delivery formats layered on the same two molecules: a gummy, a chew, a serum, and a kit that adds shampoo. There is no four-drug gel on the Hers side of our records.
Finasteride sits in only one place at Hers, inside a compounded postmenopausal serum paired with minoxidil. On the Maximus side, our records name dutasteride rather than finasteride as the DHT blocker. If a brand-name molecule is what you came for, that distinction decides which door you knock on.
These medications carry known risks, and we are not going to characterize them for you in either direction. The licensed clinician who reviews your case and writes the prescription is the right place for that conversation, and both services route you through one.
HSA money, shipping, and what we could not confirm
Maximus is the better documented of the two on logistics. Our records list it as available in all 50 states, accepting HSA and FSA funds, with free discreet shipping. If you hold a health spending account and want to put it to work on hair loss, that is a concrete reason to look at Maximus rather than a vague one.
For Hers, our records describe discreet delivery to your door and prescription by a licensed provider, and say nothing about state coverage or HSA and FSA acceptance for the hair loss program. We are not going to infer it from the fact that the brand is large. If the spending account matters to your budget, confirm it with Hers before you enroll.
We flag these gaps rather than smoothing them over because the gap is the honest answer. A comparison that reads as complete on both sides, when one side was never verified, is worse than one that tells you where to go and ask.
- Maximus, verified in our records: all 50 states, HSA and FSA accepted, free discreet shipping
- Hers, verified in our records: discreet delivery, prescription written by a licensed provider
- Hers, not in our records: state coverage, HSA and FSA acceptance for the hair loss program
Both parent companies are sitting on an open FDA letter
Hers is a brand of Hims and Hers Health, Inc., and the FDA wrote to that company on September 9, 2025 about the Hers brand specifically. The letter, MARCS-CMS 716825, went to the company's chief executive after an August 2025 review of forhers.com, and it concerns two marketing lines used for compounded semaglutide: one comparing the compounded product's active ingredient to two approved brand-name medicines, and one asserting clinical proof for its ingredients. The agency's position is that compounded products carry no FDA approval, so wording of that kind implies a sameness with approved medicines that has not been established, making the products misbranded. We checked FDA's warning letter index for MARCS-CMS 716825 on October 6, 2026: it listed no response letter and no close-out letter, so the letter has not been closed out.
Maximus Health, Inc. received warning letter MARCS-CMS 730095 on June 8, 2026, after a May 2026 review of maximustribe.com. That one runs on two tracks. The agency quoted marketing language asserting clinical study of its ingredients and asserting weight-loss outcomes, and it separately objected to the site describing the pharmacies behind its compounded products as FDA approved. On that second point the FDA was explicit that no FDA-approved or FDA-licensed designation exists for compounding pharmacies or outsourcing facilities, so describing one that way is misleading. Both findings were cited as misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. We checked FDA's warning letter index for MARCS-CMS 730095 on October 6, 2026: it listed no response letter and no close-out letter, so the letter has not been closed out.
Neither letter is about hair loss. Both are about how compounded medicines were marketed, and both companies sell compounded items in their hair catalogs as well, which is why a letter about a different aisle still belongs on this page. Read it as a reason to check how a product is described against what it actually is, not as a ruling on whether either company should be used.
How We Compared Hers vs Maximus
How we put this comparison together
Every price, format and eligibility note on this page comes from our own brand records for Hers and Maximus, each one carrying the date we last checked it. Where a figure has a date, we print the date: Hers hair loss from $12.67 a month as of 2026-07-22, Maximus from $24.99 a month as of 2026-05-07. A starting price is the floor of a catalog, so we never present one as the amount you will be charged.
Where our records are silent, this page says so instead of filling the gap. That is why you will read that we could not confirm HSA and FSA acceptance at Hers, and that we hold no FDA approval status for the Maximus oral listings. An unverified detail written as a verified one is the failure mode we are guarding against.
The regulatory section is built from FDA warning letter records, cited by their MARCS-CMS numbers and dates, and we report their status as the agency's own index shows it, including the absence of a close-out letter. We paraphrase the marketing language at issue rather than repeat it.
Final Verdict: Hers vs Maximus
The verdict
This is not a choice most people get to make, and that is the useful finding. Hers serves women, Maximus serves men, and each brand says so in its own eligibility notes, so the practical answer is whichever one is open to you.
If you are a woman: Hers is the cheaper entry of the two at $12.67 a month as of 2026-07-22, and the thing that recommends it is not the price but what the price buys, a topical minoxidil product that holds FDA approval for women's hair regrowth. The blends above it in the catalog (the gummies, the chews and the postmenopausal serum) are compounded and do not carry that status, so the cheapest plan is also the most straightforward one.
If you are a man: Maximus starts at $24.99 a month as of 2026-05-07, covers all 50 states, takes HSA and FSA money, and is built around letting you pick a pill, a gel, or both. Its compounded combination gels are the part to go in with your eyes open, since they are prepared by a licensed pharmacy and not reviewed by the FDA, and dutasteride for hair loss is an off-label use. Check the price on the site before you plan around it, because our figure is the older of the two.
Both parent companies are carrying an open FDA warning letter about how compounded medicines were marketed. Neither letter concerns hair loss, and neither is a ruling on the companies, but both are a reason to read product descriptions closely rather than trust a headline.
Frequently Asked Questions
Can a man sign up with Hers for hair loss?
No. Hers lists a man looking for hair loss treatment among the situations its program is not for, because Hers serves women only. Maximus is the men's service of this pair, and its protocols are formulated for men.
Which one starts cheaper, Hers or Maximus?
Hers, on the figures we hold. Hers hair loss starts at $12.67 a month as of 2026-07-22 for minoxidil 2% topical solution, against $24.99 a month as of 2026-05-07 for oral minoxidil at Maximus. Both are catalog floors for the simplest item rather than the cost of a full plan, and the Maximus figure is the older check of the two.
Are the Maximus hair gels FDA approved?
No. Maximus describes them as compounded formulas combining dutasteride, minoxidil, tretinoin and fexofenadine, prepared by a licensed pharmacy and not reviewed by the FDA. Compounded formulas carry no FDA approval, and the agency has not reviewed them for safety, effectiveness or quality. Our records do not state an approval status for the Maximus oral minoxidil or oral dutasteride listings, so we do not claim one.
Does either service take HSA or FSA money?
Maximus does, by its own listing, and it is available in all 50 states with free discreet shipping. For Hers, our records do not record HSA or FSA acceptance for the hair loss program either way, so ask Hers directly before you count on it.
Does Hers or Maximus prescribe finasteride?
At Hers, finasteride appears in one place in our records: a compounded postmenopausal serum that pairs it with minoxidil. No topical finasteride product holds FDA approval. On the Maximus side, the DHT blocker our records name is oral dutasteride rather than finasteride, and dutasteride used for hair loss is prescribed off-label.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
